MedTrace Logo

Urdu Translation and Psychometric Analysis of Lawton IADLS.

NCT06059768 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-12-29

No results posted yet for this study

Summary

Functional capacity and independent living skills are most crucial and important aspects to measure in older adults. Lawton IADL is an 8-item scale used to assess independent living skills. Lawton IADLS was originally developed in English. It has been translated and validated in several languages and showed excellent reliability and responsiveness. In our study Lawton IADL scale will be translated in Urdu and its psychometric analysis will be performed.The study design will be descriptive translation study. Study will be conducted in Rahimoon Welfare Foundation old age home of Lahore. Inclusion criteria will be patients of age between 65-75 years with both genders scoring 24 or more on MMSE and those who will be fluent in Urdu language. Those patients will be excluded who will have neurological problems affecting their IADLS, Cognitive/communication dysfunction or Patients with musculoskeletal impairments affecting IADLs. Participants will be asked to perform Lawton IADLs on the instruction and on completion performance will be scored. Study will be completed in two phases. Phase I will consist of Translation of original version (English) into Urdu version and pilot-testing of translated version. In phase II psychometric analysis will be performed. Data will be analyzed using SPSS version 21.

Conditions

  • Cognitive Dysfunction

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Rida Maryaum, MSPT-NM · Riphah International University

Eligibility

Min Age
65 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2023-12-01
Completion
2023-12-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06059768 on ClinicalTrials.gov